Corcept Therapeutics Inc
NASDAQ:CORT 4:00:00 PM EDT
| Market Cap (Intraday) | 4.78B |
| Current PE | 37.97 |
| Forward PE | 40.88 |
| 2yr Forward PE | 24.88 |
| 10-Day MA | $44.62 |
| 50-Day MA | $37.87 |
| 200-Day MA | $29.55 |
Corcept Therapeutics Inc Stock, NASDAQ:CORT
149 Commonwealth Drive, Menlo Park, California 94025
United States of America
Phone: +1.650.327.3270
Number of Employees: 352
Description
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.